Serveur d'exploration sur la grippe en Allemagne - Exploration (Accueil)

Index « Mots-clés originaux en anglais » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Keywords

Pour accéder à une entrée :

Les termes de plus forte occurence

556Humans (MeSH)
305Germany (MeSH)
297Germany (epidemiology)
255Female (MeSH)
250Male (MeSH)
221Influenza, Human (epidemiology)
213Influenza, Human (prevention & control)
212Adult (MeSH)
203Middle Aged (MeSH)
165Aged (MeSH)
159Adolescent (MeSH)
152Child (MeSH)
125Child, Preschool (MeSH)
122Influenza Vaccines (administration & dosage)
119Animals (MeSH)
113Young Adult (MeSH)
110Infant (MeSH)
80Risk Factors (MeSH)
76Influenza, Human (virology)
75Seasons (MeSH)
75Aged, 80 and over (MeSH)
58Influenza, Human (diagnosis)
57Incidence (MeSH)
54Vaccination (statistics & numerical data)
52Infant, Newborn (MeSH)
51Prevalence (MeSH)
48Influenza Vaccines (immunology)
47Influenza, Human (immunology)
47Influenza A Virus, H1N1 Subtype (MeSH)
45Surveys and Questionnaires (MeSH)
42Influenza in Birds (epidemiology)
41Influenza, Human (transmission)
40Influenza, Human (mortality)
40Cross-Sectional Studies (MeSH)
39Disease Outbreaks (prevention & control)
39Antibodies, Viral (blood)
39Age Factors (MeSH)
37Influenza Vaccines (therapeutic use)
37Disease Outbreaks (MeSH)
35Influenza A virus (isolation & purification)
33Influenza Vaccines (adverse effects)
32Phylogeny (MeSH)
32Influenza in Birds (virology)
32Influenza A Virus, H1N1 Subtype (isolation & purification)
32Influenza A Virus, H1N1 Subtype (immunology)
31Population Surveillance (MeSH)
31Pandemics (MeSH)
31Disease Outbreaks (statistics & numerical data)
31Antiviral Agents (therapeutic use)
30Respiratory Tract Infections (epidemiology)
30Orthomyxoviridae Infections (veterinary)
29Treatment Outcome (MeSH)
29Risk Assessment (MeSH)
29Berlin (MeSH)
29Age Distribution (MeSH)
27Retrospective Studies (MeSH)
27Influenza, Human (drug therapy)
26Vaccination (MeSH)
26Population Surveillance (methods)
25Prospective Studies (MeSH)
25Health Knowledge, Attitudes, Practice (MeSH)
25Disease Outbreaks (veterinary)
24Time Factors (MeSH)
24Practice Guidelines as Topic (MeSH)
24Orthomyxoviridae Infections (epidemiology)
23Swine (MeSH)
23Influenza A virus (genetics)
21Influenza Vaccines (MeSH)
21Attitude of Health Personnel (MeSH)
20Seroepidemiologic Studies (MeSH)
20Respiratory Tract Infections (virology)
20Pregnancy (MeSH)
20Mass Vaccination (statistics & numerical data)
20Influenza, Human (complications)
20Influenza A virus (immunology)
20Influenza A virus (classification)
20Hemagglutination Inhibition Tests (MeSH)
20Birds (MeSH)
19Swine Diseases (virology)
19Pandemics (prevention & control)
19Orthomyxoviridae Infections (virology)
19Health Surveys (MeSH)
19Case-Control Studies (MeSH)
18Influenza, Human (therapy)
18Influenza A Virus, H1N1 Subtype (genetics)
17Sentinel Surveillance (MeSH)
17Sensitivity and Specificity (MeSH)
17Risk Assessment (methods)
17Hospitalization (statistics & numerical data)
17Cross Infection (prevention & control)
16Sex Distribution (MeSH)
16Pandemics (statistics & numerical data)
16Influenza in Birds (transmission)
16Cross Infection (epidemiology)
15Acute Disease (MeSH)
14Swine Diseases (epidemiology)
14Respiratory Tract Infections (diagnosis)
14Influenza, Human (economics)
14Immunization Schedule (MeSH)
14Comorbidity (MeSH)
14Cause of Death (MeSH)
13Molecular Sequence Data (MeSH)
13Influenza A Virus, H5N1 Subtype (isolation & purification)
13Hemagglutinin Glycoproteins, Influenza Virus (genetics)
13Cohort Studies (MeSH)
12Vaccination (standards)
12Vaccination (methods)
12Travel (MeSH)
12Reverse Transcriptase Polymerase Chain Reaction (MeSH)
12Pneumococcal Vaccines (administration & dosage)
12Patient Acceptance of Health Care (statistics & numerical data)
12Neuraminidase (genetics)
12Neuraminidase (antagonists & inhibitors)
12Influenza, Human (history)
12Influenza B virus (isolation & purification)
12Influenza A Virus, H3N2 Subtype (isolation & purification)
12Influenza A Virus, H1N1 Subtype (pathogenicity)
12History, 20th Century (MeSH)
12Anti-Bacterial Agents (therapeutic use)
11Viruses (isolation & purification)
11Virus Diseases (epidemiology)
11Vaccination (psychology)
11Oseltamivir (therapeutic use)
11Models, Statistical (MeSH)
11Logistic Models (MeSH)
11Influenza, Human (nursing)
11Influenza Vaccines (supply & distribution)
11Influenza A virus (pathogenicity)
11Influenza A Virus, H3N2 Subtype (immunology)
11Genetic Variation (MeSH)
11Cost-Benefit Analysis (MeSH)
10Vaccination (adverse effects)
10Survival Rate (MeSH)
10Survival Analysis (MeSH)
10Respiratory Syncytial Virus Infections (epidemiology)
10Pneumococcal Vaccines (MeSH)
10Pneumococcal Infections (prevention & control)
10Netherlands (epidemiology)
10Influenza, Human (pathology)
10Influenza, Human (MeSH)
10Influenza Vaccines (economics)
10Influenza B virus (immunology)
10Influenza A virus (MeSH)
10Influenza A Virus, H3N2 Subtype (genetics)
10Hospitals, University (MeSH)
10Cost of Illness (MeSH)
10Communicable Diseases (epidemiology)
10Animals, Wild (MeSH)
9World Health Organization (MeSH)
9Reassortant Viruses (genetics)
9Models, Theoretical (MeSH)
9Immunization, Secondary (MeSH)
9Immunization Programs (statistics & numerical data)
9Hospitalization (MeSH)
9Health Personnel (MeSH)
9Forecasting (MeSH)
9Europe (MeSH)
9Diagnosis, Differential (MeSH)
9Communicable Disease Control (organization & administration)
9Birds (virology)
9Animals, Wild (virology)
8Vaccination (trends)
8Switzerland (epidemiology)
8Sequence Analysis, DNA (MeSH)
8Risk (MeSH)
8Reproducibility of Results (MeSH)
8Poultry (MeSH)
8Polymerase Chain Reaction (MeSH)
8Patient Education as Topic (MeSH)
8Orthomyxoviridae (immunology)
8Occupational Diseases (prevention & control)
8Nasopharynx (virology)
8Medical Staff, Hospital (statistics & numerical data)
8Interviews as Topic (MeSH)
8Influenza in Birds (pathology)
8Influenza Vaccines (standards)
8Influenza A Virus, H5N1 Subtype (genetics)
8Influenza A Virus, H1N1 Subtype (classification)
8Immunization Programs (MeSH)
8Germany, West (MeSH)
8Family Characteristics (MeSH)
8Epidemics (MeSH)
8Cross Infection (transmission)
8Chickens (MeSH)
8Base Sequence (MeSH)
8Antiviral Agents (pharmacology)
7Virus Diseases (virology)
7Virus Diseases (diagnosis)
7Virulence (MeSH)
7Vaccination (legislation & jurisprudence)
7United States (epidemiology)
7United States (MeSH)
7Sex Factors (MeSH)
7Reverse Transcriptase Polymerase Chain Reaction (methods)
7RNA, Viral (genetics)
7Paramyxoviridae Infections (epidemiology)
7Orthomyxoviridae (isolation & purification)
7Orthomyxoviridae (MeSH)
7Italy (epidemiology)
7Internet (MeSH)
7Influenza, Human (psychology)
7Influenza, Human (blood)
7Influenza A Virus, H5N1 Subtype (pathogenicity)
7Infectious Disease Transmission, Professional-to-Patient (prevention & control)
7Germany, East (MeSH)
7Dogs (MeSH)
7Computer Simulation (MeSH)
7Community-Acquired Infections (epidemiology)
7Communicable Diseases, Emerging (epidemiology)
7Communicable Disease Control (methods)
7Cats (MeSH)
7Berlin (epidemiology)
7Antigens, Viral (immunology)
7Amino Acid Sequence (MeSH)
6Virology (methods)
6Viral Vaccines (administration & dosage)
6Utilization Review (MeSH)
6Species Specificity (MeSH)
6Severity of Illness Index (MeSH)
6Respiratory Syncytial Virus Infections (virology)
6Real-Time Polymerase Chain Reaction (MeSH)
6RNA, Viral (analysis)
6Public Health (MeSH)
6Poultry Diseases (virology)
6Poultry Diseases (epidemiology)
6Poultry (virology)
6Pneumonia, Viral (diagnosis)
6Orthomyxoviridae Infections (immunology)
6Orthomyxoviridae (classification)
6Mass Vaccination (standards)
6Mass Vaccination (methods)
6Influenza, Human (physiopathology)
6Influenza in Birds (prevention & control)
6Influenza A Virus, H5N1 Subtype (MeSH)
6Hygiene (MeSH)
6Health Care Surveys (MeSH)
6Guideline Adherence (MeSH)
6France (epidemiology)
6Follow-Up Studies (MeSH)
6European Union (MeSH)
6Drug Resistance, Viral (MeSH)
6Data Collection (MeSH)
6Cross Infection (mortality)
6Cluster Analysis (MeSH)
6Chick Embryo (MeSH)
6Austria (epidemiology)
6Antibody Formation (immunology)
6Absenteeism (MeSH)
5Zoonoses (MeSH)
5Whooping Cough (prevention & control)
5Vaccination (economics)
5United Kingdom (epidemiology)
5Telephone (MeSH)
5Quality-Adjusted Life Years (MeSH)
5Prognosis (MeSH)
5Primary Health Care (MeSH)
5Polymerase Chain Reaction (methods)
5Pneumonia, Viral (mortality)
5Pneumococcal Infections (epidemiology)
5Pilot Projects (MeSH)
5Pharynx (virology)
5Patient Compliance (statistics & numerical data)
5Patient Acceptance of Health Care (MeSH)
5Pandemics (history)
5Oseltamivir (pharmacology)
5Odds Ratio (MeSH)
5Occupational Diseases (epidemiology)
5National Health Programs (MeSH)
5Multiplex Polymerase Chain Reaction (MeSH)
5Mortality (trends)
5Models, Biological (MeSH)
5Mass Vaccination (trends)
5Mass Vaccination (organization & administration)
5Mass Vaccination (MeSH)
5Influenza, Human (etiology)
5Influenza B virus (genetics)
5Influenza A virus (drug effects)
5Influenza A Virus, H3N2 Subtype (drug effects)
5Influenza A Virus, H3N2 Subtype (classification)
5Influenza A Virus, H3N2 Subtype (MeSH)
5Influenza A Virus, H1N1 Subtype (physiology)
5Influenza A Virus, H1N1 Subtype (drug effects)
5Hospitals (MeSH)
5Horses (MeSH)
5Health Status (MeSH)
5Health Promotion (statistics & numerical data)
5Health Personnel (statistics & numerical data)
5Guideline Adherence (statistics & numerical data)
5Genotype (MeSH)
5Family Health (MeSH)
5Ducks (virology)
5Disease Outbreaks (history)
5Disaster Planning (organization & administration)
5Databases, Factual (MeSH)
5Cross Infection (virology)
5Community-Acquired Infections (diagnosis)
5Communicable Disease Control (statistics & numerical data)
5Cloaca (virology)
5Cell Line (MeSH)
5Cat Diseases (epidemiology)
5Bird Diseases (virology)
5Bird Diseases (epidemiology)
5Belgium (epidemiology)
5Austria (MeSH)
5Antiviral Agents (administration & dosage)
5Amino Acid Substitution (MeSH)
5Adjuvants, Immunologic (adverse effects)
5Adjuvants, Immunologic (administration & dosage)
4Zanamivir (pharmacology)
4Viruses (genetics)
4Virus Shedding (MeSH)
4Vaccines, Inactivated (immunology)
4Vaccines, Combined (administration & dosage)
4Vaccines, Attenuated (administration & dosage)
4Vaccines (administration & dosage)
4Turkeys (virology)
4Trachea (virology)
4Tetanus Toxoid (administration & dosage)
4Temperature (MeSH)
4Swine (virology)
4Serologic Tests (MeSH)
4Sequence Alignment (MeSH)
4Sentinel Surveillance (veterinary)
4Safety (MeSH)
4Risk Management (methods)
4Reverse Transcriptase Polymerase Chain Reaction (veterinary)
4Respiratory Tract Diseases (epidemiology)
4Registries (MeSH)
4Public Opinion (MeSH)
4Primary Health Care (statistics & numerical data)
4Practice Patterns, Physicians' (MeSH)
4Poultry Diseases (prevention & control)
4Portugal (epidemiology)
4Population Density (MeSH)
4Polymerase Chain Reaction (veterinary)
4Pneumonia, Pneumococcal (prevention & control)
4Pneumonia (epidemiology)
4Physician's Role (MeSH)
4Particle Size (MeSH)
4Orthomyxoviridae Infections (transmission)
4Netherlands (MeSH)
4Mutation (MeSH)
4Molecular Diagnostic Techniques (methods)
4Models, Organizational (MeSH)
4Microbial Sensitivity Tests (MeSH)
4Internationality (MeSH)
4Influenza, Human (classification)
4Influenza in Birds (diagnosis)
4Influenza A Virus, H5N1 Subtype (classification)
4Influenza A Virus, H1N2 Subtype (isolation & purification)
4Infectious Disease Transmission, Patient-to-Professional (prevention & control)
4Immunoglobulin G (blood)
4Horse Diseases (epidemiology)
4Hemagglutination Inhibition Tests (veterinary)
4Health Promotion (methods)
4Health Policy (MeSH)
4Health Care Costs (MeSH)
4Health Behavior (MeSH)
4Haemophilus Vaccines (administration & dosage)
4Global Health (MeSH)
4Genome, Viral (MeSH)
4Genes, Viral (MeSH)
4General Practice (MeSH)
4France (MeSH)
4Feces (virology)
4Evidence-Based Medicine (MeSH)
4Epidemiological Monitoring (MeSH)
4Enzyme-Linked Immunosorbent Assay (veterinary)
4Dog Diseases (epidemiology)
4Disease Notification (statistics & numerical data)
4Diphtheria-Tetanus-Pertussis Vaccine (administration & dosage)
4Cross Reactions (MeSH)
4Cross Infection (diagnosis)
4Critical Care (MeSH)
4Complement Fixation Tests (MeSH)
4Community-Acquired Infections (mortality)
4Community-Acquired Infections (drug therapy)
4Communicable Diseases, Emerging (virology)
4Communicable Diseases, Emerging (veterinary)
4Communicable Disease Control (standards)
4Coinfection (virology)
4Cardiovascular Diseases (mortality)
4Bacterial Vaccines (administration & dosage)
4Bacterial Infections (microbiology)
4Bacteria (isolation & purification)
4Attitude to Health (MeSH)
4Antigens, Viral (genetics)
4Antibodies, Viral (immunology)
4Antibodies, Bacterial (blood)
4Acute Disease (epidemiology)
3Zoonoses (virology)
3Zoonoses (transmission)
3Zanamivir (therapeutic use)
3World War I (MeSH)
3Virus Diseases (veterinary)
3Virus Diseases (therapy)
3Virus Diseases (prevention & control)
3Virus Cultivation (methods)
3Viral Proteins (genetics)
3Viral Matrix Proteins (genetics)
3Viral Load (MeSH)
3Vaccines, Inactivated (adverse effects)
3Vaccines, Inactivated (administration & dosage)
3Vaccines, Combined (immunology)
3Vaccines, Attenuated (standards)
3Vaccination (ethics)
3Travel (statistics & numerical data)
3Tetanus (prevention & control)
3Tertiary Care Centers (MeSH)
3Swine Diseases (transmission)
3Sweden (epidemiology)
3Spain (epidemiology)
3Societies (MeSH)
3Serotyping (MeSH)
3Sequence Homology (MeSH)
3Self Report (MeSH)
3Rotavirus Vaccines (administration & dosage)
3Risk Assessment (statistics & numerical data)
3Respiratory Tract Infections (therapy)
3Respiratory Tract Infections (microbiology)
3Respiratory Tract Diseases (mortality)
3Respiratory Syncytial Viruses (isolation & purification)
3Respiratory Syncytial Virus, Human (isolation & purification)
3Respiratory Syncytial Virus Infections (diagnosis)
3Respiration, Artificial (MeSH)
3Residence Characteristics (MeSH)
3Regression Analysis (MeSH)
3Reference Standards (MeSH)
3Reassortant Viruses (isolation & purification)
3Reassortant Viruses (classification)
3Randomized Controlled Trials as Topic (MeSH)
3Quality Control (MeSH)
3Public Health Administration (MeSH)
3Product Surveillance, Postmarketing (MeSH)
3Pregnancy Complications, Infectious (prevention & control)
3Pregnancy Complications, Infectious (epidemiology)
3Practice Patterns, Physicians' (statistics & numerical data)
3Poliovirus Vaccine, Inactivated (immunology)
3Poliovirus Vaccine, Inactivated (administration & dosage)
3Pneumonia, Viral (epidemiology)
3Pneumonia, Viral (drug therapy)
3Pneumonia, Bacterial (mortality)
3Pneumonia, Bacterial (epidemiology)
3Pneumococcal Vaccines (immunology)
3Picornaviridae Infections (epidemiology)
3Pertussis Vaccine (administration & dosage)
3Patient Selection (MeSH)
3Patient Participation (statistics & numerical data)
3Patient Isolation (MeSH)
3Particulate Matter (analysis)
3Paramyxoviridae Infections (virology)
3Papillomavirus Vaccines (administration & dosage)
3Outpatients (MeSH)
3Orthomyxoviridae Infections (prevention & control)
3Orthomyxoviridae (growth & development)
3Orthomyxoviridae (genetics)
3Occupational Exposure (MeSH)
3Nursing Staff, Hospital (statistics & numerical data)
3Newcastle disease virus (isolation & purification)
3Newcastle Disease (epidemiology)
3Neutralization Tests (MeSH)
3Neuraminidase (immunology)
3Neuraminidase (chemistry)
3Nasopharynx (microbiology)
3Narcolepsy (epidemiology)
3Mutation, Missense (MeSH)
3Multivariate Analysis (MeSH)
3Multiple Sclerosis (immunology)
3Multiple Sclerosis (epidemiology)
3Motivation (MeSH)
3Mortality (MeSH)
3Molecular Epidemiology (MeSH)
3Models, Economic (MeSH)
3Models, Econometric (MeSH)
3Mexico (MeSH)
3Metapneumovirus (isolation & purification)
3Medical Staff, Hospital (psychology)
3Meat (virology)
3Mandatory Reporting (MeSH)
3Lung (pathology)
3Length of Stay (MeSH)
3Intensive Care Units (MeSH)
3Information Dissemination (methods)
3Influenza in Birds (mortality)
3Influenza A Virus, H7N7 Subtype (pathogenicity)
3Influenza A Virus, H5N8 Subtype (pathogenicity)
3Influenza A Virus, H5N1 Subtype (immunology)
3Influenza A Virus, H1N2 Subtype (genetics)
3Influenza A Virus, H1N2 Subtype (classification)
3Infection Control (MeSH)
3Immunosuppressive Agents (therapeutic use)
3Immunization Programs (organization & administration)
3Immunization (adverse effects)
3Immunization (MeSH)
3Immune Sera (MeSH)
3Humidity (MeSH)
3History, 19th Century (MeSH)
3Hepatitis B Vaccines (administration & dosage)
3Hemagglutinins, Viral (genetics)
3Hemagglutinins (genetics)

Manipulations en shell (Unix/Dilib)

HfdCat GrippeAllemagneV4/Data/Main/Exploration/KwdEn.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 17:53:30 2020. Site generation: Sat Mar 27 17:40:37 2021